Organon Pharma Indonesia Tbk. vs Express Transindo Utama Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Express Transindo Utama Tbk. trades at Rp15 (market cap 143.13B, 93.27M 24h volume). The key difference: Express Transindo Utama Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| SCPI | TAXI | |
|---|---|---|
Market Cap | 104.4B | 143.13B |
Volume | — | 93.27M |
Lot | — | 932.74K |
Turnover | — | 1.37B |
Average Price | — | 14.65 |
Value | — | 1.37B |
Indicative Equilibrium Price | — | 15 |
Indicative Equilibrium Volume | — | 20.9K |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →Express Transindo Utama, PT (the Company) formerly PT Kasih Bhakti Utama was established on June 11, 1981 based on Notarial Deed No. 9 of Max Lahoendoeitan, S,H., substitude notary of Nico Rudolf Makahanap, S.H., notary in Jakarta which was amended by Notarial Deed No. 8 dated February 3, 1986 of Nico Rudolf Makahanap S.H., notary in Jakarta.
Read more on TAXI →